Skip to main content
. 2019 Apr;11(4):1190–1201. doi: 10.21037/jtd.2019.04.32

Table 2. Subject perioperative data [x¯±s, n (%)].

Subject perioperative data Group A (n=22) Group C (n=31) t (χ2) P
Fluids (mL) 2,361±1,131 2,229±674 0.461 0.647
Red cells (mL) 3.80±1.25 3.33±1.42 0.634 0.531
Plasma (mL) 696±258 536±221 1.643 0.108
Blood loss (mL) 1,524±458 1,175±327 2.111 0.040
Urine (mL) 1,429±406 1,546±512 −0.443 0.660
Surgery time (hours) 8.48±3.33 8.25±2.92 0.267 0.790
CPB time (hours) 3.49±0.76 3.63±0.85 −0.588 0.559
Circulatory arrest time (hours) 2.11±0.56 2.16±0.58 −0.314 0.755
Lowest rectal temperature during CPB (°C) 24.1±0.3 24.3±0.3 −0.467 0.642
CABG in surgery, n (%) 1 (4.5) 2 (6.5) 0.088 0.767
Postoperative cerebral complications, n (%) 0 (0) 1 (3.2) 1.232 0.267
Postoperative NT-proBNP (pg/mL) 92.28±42.70 99.79±43.03 −0.635 0.528
Abnormal postoperative NT-proBNP, n (%) 2 (9.1) 2 (6.5) 0.039 0.844
Mechanic ventilation time in ICU (hours) 27.24±8.37 17.33±7.36 4.528 <0.001
Stay in ICU (hours) 42.27±10.85 33.45±9.05 3.218 0.002
Hospital stay (days) 17.77±5.00 13.48±3.97 3.475 0.001
In-hospital mortality, n (%) 2 (9.1) 3 (9.7) 0.005 0.943

CPB, cardiopulmonary bypass; CABG, coronary artery bypass graft; NT-proBNP, N terminal pro B type natriuretic peptide.